Johnson & Johnson has filed two applications to expand the use of its drug Tremfya for treating pediatric patients with psoriasis and juvenile psoriatic arthritis.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
J&J Seeks FDA Approval for Tremfya for Psoriasis in Kids
